首页> 美国卫生研究院文献>Data in Brief >A compiled dataset of molecular pathways associated with fusion genes identified in pediatric cancers
【2h】

A compiled dataset of molecular pathways associated with fusion genes identified in pediatric cancers

机译:与儿科癌症中鉴定的融合基因相关的分子途径的编译数据集

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fusion genes can serve as actionable biomarkers for diagnosis, prognosis or therapeutic stratification in the clinic. Pathways associated with fusion genes identified in different pediatric cancers are compiled in this article. Fusion genes reported in each cancer were collected using the PubMed search option with the keywords ‘fusion transcript’, ‘fusion gene,’ ‘chromosomal translocation,’ or ‘DNA translocation’ along with the corresponding pediatric cancer type. Research articles that identified fusion genes using conventional Fluorescence in situ hybridization (FISH) or quantitative real-time polymerase chain reaction (RT-PCR) methods or high-throughput RNA or DNA sequencing were included. The collected fusion gene data were compiled for each cancer and analyzed to identify their functions related to cancer and associated pathways using Ingenuity Pathway Analysis (IPA) and ClueGO software programs. Similarities in associated pathways across different cancers were also analyzed using IPA to identify commonly affected genes and pathways. This value-added and functionally annotated dataset will be an excellent resource for pediatric cancer researchers and clinicians interested in exploring fusion genes in different cancers. This article is a companion article to ‘Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy’[1].
机译:融合基因可作为可行的生物标志物,用于诊断,预后或治疗临床治疗分层。在本文中编制了与不同儿科癌症中鉴定的融合基因相关的途径。使用PubMed搜索选项在每种癌症中报告的融合基因,用关键词“融合转录物”,“融合基因”,“融合基因”,“染色体易位”,“DNA易位”以及相应的小儿癌类型。包括使用常规荧光原位杂交(鱼)或定量实时聚合酶链反应(RT-PCR)方法或高通​​量RNA或DNA测序的研究制品。编制收集的融合基因数据,用于每种癌症,分析,以鉴定使用聪明途径分析(IPA)和ClueGo软件程序与癌症和相关途径相关的功能。还使用IPA分析不同癌症的相关途径的相似性以鉴定通常受影响的基因和途径。这种增值和功能注释的数据集将是对儿科癌症研究人员和临床医生对不同癌症融合基因感兴趣的优秀资源。本文是“融合基因作为儿科癌症生物标志物”的伴侣文章:对当前状态和诊断和个性化治疗的适用性审查[1]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号